1 In the
final 14 days of life, 357 (10%) received chemotherapy.
2 -of-life care, including chemotherapy in the
final 14 days of life, intensive care unit (ICU) admissi
3 in hospice, enrollment in hospice during the
final 3 days of life, and enrollment in hospice while no
4 invasive or life-extending procedures in the
final 30 days of life, enrollment in hospice, enrollment
5 gency room (ER) or hospital admission in the
final 30 days of life, invasive or life-extending proced
6 , intensive care unit (ICU) admission in the
final 30 days of life, more than one emergency room (ER)
7 e printing method, and the structures of the
final 3D-printed products.
8 To report the
final (
5-year) results of a prospective study evaluating
9 xclusive use of gadoterate meglumine (plus a
final additional nonenhanced MR imaging examination) wer
10 clinical and endoscopic remission), with the
final aim of blocking their progression and preventing b
11 With the
final aim of testing the therapeutic efficacy of UCB in
12 vated concentration of BP-3 for 32 days; the
final air concentration was 4.4 mug/m(3).
13 ng from FPP to GPP, until replacement of the
final alpha-helix, whereupon cyclopropanation and branch
14 ng functional MRI in 28 healthy adults, with
final analyses based on 20 individuals following extensi
15 At the
final analysis (Aug 1, 2016), 31 patients had had a prog
16 Of the 2654 women in the
final analysis (mean [SD] age, 31.0 [5.7] years), most w
17 dable MRI), leaving a sample size of 243 for
final analysis (mean [SD] age, 72.8 [9.1] years; 116 men
18 The
final analysis cohort included 88 eyes in 3 groups: mont
19 This is the
final analysis from GATSBY, a randomised, open-label, ad
20 The
final analysis included 4131 patients (2661 in the boost
21 Survival was assessed every 12 weeks, and
final analysis occurred after all patients were followed
22 d 227 participants, with 205 included in the
final analysis of the primary outcome.
23 The cutoff for
final analysis was 450 patients with 346 deaths.
24 The date of the
final analysis was October 20, 2016.
25 In the
final analysis, a significantly higher percentage of inf
26 We present the
final analysis, although at the time of the database loc
27 6-83 years]) with 23 lesions included in the
final analysis, the mean (SD) surgical defect area estim
28 ied inclusion criteria, were included in the
final analysis.
29 patients enrolled, 730 were included in the
final analysis.
30 nd point and the secondary end points in the
final analysis.
31 ed after 1 year and this report presents the
final analysis.
32 bo follow-up period, but was included in the
final analysis.
33 res, 126 in each group, were included in the
final analysis.
34 ups of children could not be included in the
final analysis: 147 migrated out of the study area (67 i
35 Of the
final analytic sample of 9512 enlisted soldiers who atte
36 whom surgery type was known constituted the
final analytic sample.
37 al revealed that time from groin puncture to
final angiographic result was shorter with patients unde
38 of raw data sequencing into a comprehensive
final annotated report of predicted superenhancers.
39 Thus,
final application of the developed methodology to the co
40 ure also highlights a loss of focus from the
final application.
41 ing of chlorophyll f at 740 nm, we observe a
final approximately 150 ps decay assigned to trapping by
42 highly strained 1,2-trans ring fusion of the
final architecture.
43 eleased during fermentation to influence the
final aroma of wine.
44 After histology reports were available,
final assessments of usability were made.
45 a foundation for future improvements in the
final beer-making process.
46 fference between the median preoperative and
final best-corrected visual acuity (BCVA) was assessed a
47 Uric acid is a
final breakdown product of purine catabolism in humans.
48 Final case adjudication was based on conclusive diagnost
49 morphology in high throughput, but only the
final cell counts are commonly used for clinical decisio
50 thylation status, and their correlation with
final challenge symptom scores were determined.
51 ter in raw fresh cocoa beans to 4mg/g in the
final chocolate product.
52 6mg epicatechin equivalents per gram in the
final chocolate.
53 give more weight to inlying elements in the
final choice ("robust averaging").
54 t a flat model that directly selects between
final choices accounts more parsimoniously for the repor
55 was incidence of hearing loss 4 weeks after
final cisplatin dose.
56 the 874 individuals ever diagnosed with MCI,
final clinical diagnoses were varied: 39.2% died with an
57 Final clinical sensitivity values of the Aries Flu A/B &
58 Alternative splicing (AS) that occurs at the
final coding exon (exon 47) of the Cav2.1 voltage-gated
59 ad an identifiable matching control subject (
final cohort, 11 patients and 11 control subjects).
60 The yield and
final color quality of spray dried PCC anthocyanins were
61 d allosteric stimulation of FVIIa provided a
final complex with FVIIa-like activity in solution, whil
62 ad been collected in acetic acid (0.5%; mean
final concentration).
63 ited for samples that contain metabolites at
final concentrations between 1 nM and 10 muM, and they a
64 ures through neural network learning for the
final contact map prediction.
65 Final content of reducing sugars, ethanol, acetic acid,
66 s postulated by us as an intermediate to the
final conversion to carboxylic acids.
67 centers between July 2011 and June 2016; the
final date of follow-up was June 29, 2016.
68 nties (June 24, 2009, to August 26, 2015-the
final date of follow-up).
69 ction mechanism, reaction intermediates, and
final degradation products were analyzed by UV/vis, NMR,
70 ining process and remain unaltered after the
final deodorizing step.
71 Final diagnoses were based on local and central results.
72 Final diagnoses were established by histopathologic exam
73 inations as regards the suspected causes and
final diagnoses.
74 over the same period who had an alternative
final diagnosis (CJD mimics).
75 en than in men in terms of time to reach the
final diagnosis and downstream testing.
76 malignancy, there was a significant delay to
final diagnosis in the CT group compared with the (18)F-
77 to an appropriate differential diagnosis and
final diagnosis is highlighted in our case report.
78 The
final diagnosis of AMI was independently adjudicated usi
79 From 355 cases with
final diagnosis of PTB, 263 (71.8%) had definite diagnos
80 The
final diagnosis was adjudicated by 2 independent cardiol
81 The
final diagnosis was adjudicated in patients presenting w
82 The
final diagnosis was established based on selective angio
83 All images led to a clear
final diagnosis.
84 f the detachment process but also modify the
final distribution of the bacteria on the surface.
85 seline, FUV1, FUV2 and at a FUV 1 year after
final dose (FUV3; 2014 Cohort only).
86 ve levels, with 2 days at each dose, and the
final dose achieved on day 9.
87 ard of care, every 4 weeks for 24 weeks (the
final dose was given at week 20).
88 dose of study treatment to 30 days after the
final dose).
89 14 days after the
final dose, the groups were each crossed over to the oth
90 e mice extended beyond 70 days following the
final dose.
91 w-up visit [FUV] 1) and 3 (FUV2) weeks after
final dose.
92 drinking water treatment processes shape the
final drinking water microbial community via selection o
93 ed are the synthetic studies that led to the
final eight-step synthesis of dehaloperophoramidine.
94 ead movements, abducens motoneurons form the
final element of the reflex arc that integrates visuoves
95 tsky Rise was remarkably emergent during its
final emplacement phase.
96 Practice Guidelines Committee, approved the
final endorsement.
97 Besides satisfying annual
final energy demand, the model constraints comprise avai
98 Expression of the gene encoding the
final enzymatic step in solanapyrone biosynthesis was sp
99 ve propensities for each to propagate to the
final folded native state.
100 ly (18.1 vs. 18.7 mm, P < 0.0001) and at the
final follow-up (21.4 vs. 22.1 mm, P = 0.0004).
101 m August 1, 2010, through December 31, 2011;
final follow-up assessment was in April 2014.
102 een January 1, 2001, and June 30, 2014, with
final follow-up date December 31, 2014.
103 The
final follow-up date was December 31, 2014.
104 o-controlled, randomized trial (July 2013 to
final follow-up October 2014) conducted in 54 family pra
105 ary 1, 2012, through December 31, 2016, with
final follow-up on December 31, 2016.
106 The
final follow-up visit was on August 15, 2017.
107 Final follow-up was August 2012.
108 Final follow-up was completed on May 9, 2016.
109 p was conducted at 30 days and 6 months, and
final follow-up was on June 16, 2015.
110 ecreased significantly to 318 +/- 159 mum at
final follow-up, AG (p < 0.0001).
111 up and improved slightly to 0.53 +/- 0.71 at
final follow-up, AG (p = 0.46).
112 ptember 2016), with a follow-up of 6 months (
final follow-up, March 28, 2017).
113 up and improved slightly to 0.60 +/- 0.36 at
final follow-up, RG (p = 0.64).
114 between January 1, 2007, and June 30, 2013 (
final follow-up: December 31, 2013), were assessed.
115 h the same amount of added calcium salt, the
final G' of milk gel followed the same order.
116 The
final genetic map contains 7,192 successfully mapped mar
117 Solanaceae were well diversified long before
final Gondwanan breakup.
118 ce included recommendation statements in the
final guideline only if they reached an 80% acceptance t
119 between children with peak growth at 90% of
final height and skeletal maturity closely reflecting gr
120 This ability to use 90% of
final height as easily identified important maturity sta
121 which reported growth as change in height or
final height were included.
122 The
final HILIC/ESI-MS/MS method is applied for the analysis
123 cs with severe NMR line broadening until the
final hydrogen bonds are formed.
124 = 101), and one 3-6 mo later to document the
final implemented management (Q3; n = 56).
125 ngth >/=24 mm, deferred stenting reduced the
final infarct size (6% LV; IQR: 2% to 18% vs. 13% LV; IQ
126 The primary endpoint was
final infarct size.
127 splenic tissues were harvested 7 days after
final injection and subjected to inductively coupled pla
128 aging was used as the reference standard for
final IS and viability assessment.
129 demonstrated the best linear correlation to
final IS at a threshold of >46% (R=0.96; 95% CI, 0.92-0.
130 rior to acute LGE in terms of agreement with
final IS.
131 A
final lactulose concentration of 6.7+/-0.4g/L was determ
132 silencing phase that largely determine their
final life spans.
133 Final losses of up to 74, 45 and 78% were found for AA,
134 We identified predictors of
final macular status, and developed two predictive model
135 The
final management decision should be individualized for s
136 1, Rio2 and Pno1 collectively preclude their
final maturation, thereby preventing untimely tRNA and m
137 The
final model demonstrated good performance for both RVAD
138 A
final model evaluation was conducted based on representa
139 A multiple-regression analysis led to a
final model explaining FLI best through BMI, waist circu
140 The
final model identified a mean (95% confidence interval)
141 g to the prognostic index developed from the
final model.
142 The
final models with R(2) values ranging from 0.64 for p-xy
143 ycaemic control (single-blind placebo in the
final month).
144 pace that converges separately onto the same
final motor neuron state as the standard path.
145 ation stroke treated with MT and achieving a
final mTICI score 2b or 3.
146 maintained significance of P </= .15 in the
final multivariable models.
147 with a large variety of amines provided the
final N-acylguanidines, with the overall formation of on
148 tic transformation mechanism that leads to a
final nanolaminate structure of alpha'' (orthorhombic) m
149 excluded from further analysis because of a
final noninfectious etiology or lack of further follow-u
150 et al risk model, and the C statistic of the
final noninvasive risk model was determined using bootst
151 time without compromising the quality of the
final NPs.
152 pears to have a very significant role on the
final number of simulated double strand breaks.
153 1) and from baseline state (VISUAL-2) to the
final or early termination visit was determined in each
154 rotation that brings them on-axis with their
final orientation.
155 Final OS among patients not receiving previous pelvic ra
156 e to begin any of these inductions while the
final outcome depends on the tissue emitting the later s
157 Eyes with a
final outcome of NLP were further reviewed to determine
158 Nineteen eyes had a
final outcome of NLP, representing 16.0%.
159 iented sister kinetochores, representing the
final outer kinetochore component recruited prior to ana
160 ty of peaks is of pivotal importance for the
final output of the proposed method, we provide a compre
161 We report results from the
final overall survival analysis of the TH3RESA trial.
162 then becoming a nucleophilic oxidant in the
final oxidation of an aryl-nitroso intermediate to the a
163 ound to occur at ambient temperature and the
final oxidative cyclization occurs when the substrate is
164 The third- and-
final part proposes ideas for further improvement in blu
165 e ARP2/3 complex signaling pathway, a common
final pathway for multiple signaling cascades that regul
166 The
final patient developed vomiting and diarrhea, started p
167 tations, the algorithm displays an excellent
final performance, with an area under the curve (AUC) of
168 A
final PET quantitative stability assessment for simultan
169 g the time interval between RO treatment and
final pH adjustment can significantly reduce NDMA re-for
170 , and ketones characterized the aroma of the
final pineapple vinegar, whilst off-flavors were signifi
171 main stem branching, rosette branching, and
final plant height and observed several strong positive
172 Neither TMBPF nor the migrants from the
final polymeric coating increased proliferation of estro
173 e geometry and materials architecture of the
final porous fibers.
174 higher after POT+SB dilation or SB stenting+
final POT versus after MV stenting and POT.
175 ed to >0.75 after SB dilation or SB stenting+
final POT.
176 estimated association rates and improved our
final prediction by using a cross-validation test.
177 The
final prediction model included age (A), biomarkers (B)
178 1), 1711.8mgkg(-1) and 2959.2mgkg(-1) in the
final product (T0), and after 1 (T1) and 3 (T3) months o
179 olase located in family GH105, producing the
final product 4-deoxy-beta-l-threo-hex-4-enepyranosyl-ur
180 nt purification strategies to obtain a clean
final product and thus avoid ambiguities in the source o
181 a soluble intermediate and then an insoluble
final product magnesium iodide.
182 pathway, without substantially changing the
final product of aggregation.
183 s(III) and methylarsenite (MAs[III]), with a
final product of dimethylarsenate (DMAs[V]).
184 assays and plant extracts indicate that the
final product of the ALD1-catalyzed reaction is enaminic
185 Even if the
final product of the exchange, in both cases, was rock-s
186 ructure characterization typically image the
final product or laboriously determine the presence of i
187 vironmentally friendly methodologies and the
final product presented acceptable sensory characteristi
188 This enrichment exhibited the largest NH2OH:
final product ratio (1.92%), followed by N. multiformis
189 The consumer acceptance (n=200) of
final product showed the sensory scores in the range of
190 truct to a CAR-signalling tail and named the
final product TCR-CAR.
191 Since the salt represents around 4% of the
final product, it will therefore strongly influence the
192 Cyclooxygenases (COXs) and their
final product, prostaglandin E2 (PGE2), are known to pla
193 operties, applications, economy, etc. of the
final product.
194 lite cultivars with specific end-uses of the
final product.
195 scovering materials or understanding how the
final products form.
196 product distribution covers about 90% of the
final products, and we are able to discriminate between
197 As for
final products, the highest T-2/HT-2 concentrations were
198 rtant roles for minimizing mycotoxins in the
final products, while the recipe formulation has an impa
199 intermediates along the reaction pathway to
final products.
200 e the precursors of the mono- and bis-adduct
final products.
201 e efficient to remove the urethanes from the
final products.
202 Degree of hard tissue loss and type of
final prosthetic restoration should be carefully conside
203 ions in the sample and greatly enhancing the
final QDS rate in the finite-size scenario.
204 g 974 in the baseline quarter and 972 in the
final quarter who met inclusion criteria.
205 the cell; 2) Long processing time before the
final readout makes it difficult to capture transient si
206 An all-or-none step led to
final release of ESCRT-III and Vps4.
207 e reactors though was due to starvation, and
final removal rates did not differ between reactors inoc
208 This is the
final report of the first case-control study evaluating
209 The
final result should be a generalizable model that takes
210 onal radiology played a decisive role in the
final result.
211 This trial has been completed and the
final results are reported.
212 The trial has been completed and the
final results are reported.
213 The
final results of the PREVAIL trial, both alone and as pa
214 Purpose To report the
final results on treatment outcomes of a randomized tria
215 The antioxidant activity had a
final retention of 38.5-59.5%.
216 The
final risk adjustment model included procedure-type risk
217 The
final risk score included the following predictors: havi
218 lues were assigned to predictive factors and
final risk score is correlated with the percent risk of
219 After progression, patients made a
final rotation to either pazopanib or everolimus monothe
220 chronously through schizogony, with only the
final round of DNA replication and segregation being syn
221 rea reproducibility approximately 2-fold, to
final RSD values of 2.2-4.7% (n = 900).
222 For word-
final /
s, z/ detection, performance was significantly be
223 In summary, Fcomp improved word-
final /
s, z/ detection.
224 Results Among the
final sample (N = 38,111), risk-adjusted rates of claim
225 schedule as the combination arm) and with a
final sample size of 454 patients.
226 identified, 24 studies were included in the
final sample.
227 In VISUAL-1, the change from
final score to best score in NEI VFQ-25 was -1.30 for ad
228 Secondary outcomes included initial vs
final scores by country, scores among surgeons trained b
229 A
final section draws attention to the significance and ap
230 iction interval from the presentation of the
final sentence item.
231 gle dendrites and somata of L5 neurons', the
final sentence of the second paragraph incorrectly cited
232 The accuracy of the
final Sequence-Specific Retention Calculator (SSRCalc) S
233 Purc infers the
final sequences from the raw reads via an iterative appr
234 e comparison method, the correlations of the
final SFFQ were similar with 7DDRs (mean r = 0.63) and A
235 hose individual growth rates differ, yet the
final shape of organs is highly robust.
236 s with a focus on the rational design of the
final shapes.
237 2@Au92@Au54, which is further protected by a
final shell of Au48.
238 The
final SMH values were compared to the starting values (a
239 ness (SMH) using Knoop microhardness tester (
final SMH), and roughness and 2D profiles using atomic f
240 d to further refine the model and choose the
final sparse SNPs.
241 automatically tracked spindles indicate that
final spindle position is determined largely by cell mor
242 unseled that the Fontan is typically not the
final stage of single-ventricle palliation.
243 as a compact conformer is favored during the
final stages of dehydration.
244 of the spatial and temporal dynamics of the
final stages of embolism removal.
245 PY detects aggregation of peroxisomes during
final stages of programmed cell death and can be used as
246 nterprotamine sulfur-sulfur bonds during the
final stages of sperm maturation.
247 e of events coordinating K(+) uptake and the
final stages of vesicle traffic.
248 First, anemia is the
final state in iron depletion.
249 can Society for Human Genetics, endorsed the
final statement.
250 onstrate how this can lead to a new class of
final states different from those possible with dissipat
251 ced by 10 and 13 electrons, respectively, to
final states with all bridging ligands doubly reduced an
252 cycle adopts a boat-like conformation at the
final station, which contrasts with the chair-like confo
253 strontium isotope ratio is evidenced in the
final statistical discrimination of the origin of hams.
254 e and phytyl pyrophosphate, required for the
final step in chlorophyll a synthesis.
255 (now known as SELENOI), responsible for the
final step in Kennedy pathway forming phosphatidylethano
256 yl alcohol dehydrogenase (CAD) catalyzes the
final step in monolignol biosynthesis, reducing sinapald
257 atic activity of EPT1, thereby hindering the
final step in phosphatidylethanolamine synthesis.
258 Distal sodium transport is a
final step in the regulation of blood pressure.
259 6-phosphatase, an enzyme which catalyses the
final step of gluconeogenesis and glycogenolysis.
260 , ferrochelatase, the enzyme involved in the
final step of heme synthesis, is deficient in these pati
261 of TCA was most effective when added in the
final step of the clean-up procedure instead of during e
262 the midhypocotyl, whose expansion drives the
final step of this developmental transition under optima
263 The
final step of this route demonstrates the chemical feasi
264 At the
final step of VEPART, robustness is assessed by identify
265 ne group that leads to a different series of
final steps in one Rh-based catalytic cycle, thereby ena
266 The slowest step is the
final structural maturation of the PRD.
267 Guided by computational studies for the
final structure assignment, the stereogenic centers at t
268 The
final study population included 1,331 EOC cases and 3,01
269 The
final study population included 176 (18)F-FDG PET/CT stu
270 ion therapy, who underwent MR imaging before
final surgery between June 2011 and July 2015.
271 iOCT measurements of interface fluid after
final surgical manipulations and immediately before leav
272 Rates of
final surgical procedure (lumpectomy, unilateral mastect
273 changes in postlumpectomy surgery rates, and
final surgical treatment following a 2014 consensus stat
274 source into dust substantially increases the
final SVOC concentration in dust in contact with the sou
275 that, should it occur, would lead to a given
final systemic loss.
276 nly the first occurrence of any event in the
final tally within a conventional time to first event an
277 of dichloramine formed prior to reaching the
final target pH.
278 A
final test demonstrated quantitative stability during a
279 and one workshop, were narrowed down to the
final top ten uncertainties of priority for future resea
280 ecursor synthesis pathway, but differ in the
final transfer of the TA chain to either peptidoglycan o
281 t preferences; as well as agreement over the
final treatment decision.
282 e ice shelf, occurred in 1945 (+/-12 years);
final ungrounding of the ice shelf from the ridge occurr
283 ime from liquid precursor continually to the
final uniform film.
284 045) were associated with increased risk for
final VA <20/200 in the multiple regression model (OR, 4
285 4.41 +/- 6.76 months from presentation, mean
final VA was 20/283 (logMAR equivalent of 1.15 +/- 0.15)
286 llomas disappeared within 2 months after the
final vaccination.
287 Final values of 3.7 and 3.0% were obtained in static and
288 rofound changes during the production of the
final virus stock in cell culture.
289 s significantly reduced the growth rates and
final virus yields of viruses without inhibiting the exp
290 ile significant decreases in the setback and
final viscosities were only detected in oil samples, but
291 eceived intravitreal corticosteroids and had
final visual acuities of 20/40, 20/70, and hand movement
292 dings, treatment regimens, culture data, and
final visual acuities.
293 Risk factors for
final visual acuity (VA) were analyzed, and rate of stra
294 scularization were important determinants of
final visual acuity in eyes with the cuticular drusen ph
295 Interval and
final visual outcomes (logarithm of the minimum angle of
296 was 20/400 (range 20/60 to hand motion) and
final was 20/50 (range 20/30 to 20/400) (P < .05).
297 s the total number of hot flushes during the
final week of both treatment periods.
298 lome of roach (Rutilus rutilus) exposed to a
final WwTWs effluent for 15 days.
299 All
final year students were invited to participate.
300 58 (22-167) per person, respectively, by the
final years of scale-up.